Holobiome

Cambridge, United States

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

$9.0M raised

Oct 2024

Seed

Top Investors

Valor Equity PartnersAstanor VenturesiSelect FundSatori CapitalAlexandria LaunchLabs

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Holobiome raised?

Holobiome has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in October 2024.

Who are Holobiome's investors?

Holobiome's investors include Valor Equity Partners, Astanor Ventures, iSelect Fund, Satori Capital, Alexandria LaunchLabs.

Where is Holobiome headquartered?

Holobiome is headquartered in Cambridge, United States.

What does Holobiome do?

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

What stage is Holobiome at?

Holobiome is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 9, 2024.

MLA

"Holobiome — Funding & Investors." VCBacked, October 9, 2024, https://www.vcbacked.co/company/holobiome. Accessed June 4, 2026.

APA

VCBacked. (2024). Holobiome — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/holobiome

Wikipedia (cite web)

{{cite web |title=Holobiome — Funding & Investors |url=https://www.vcbacked.co/company/holobiome |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 9, 2024.